Some more background reading on IMM-124E:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534391/
https://www.ncbi.nlm.nih.gov/pubmed/22236001
Hopefully they plan to publish/present the trial results at in a journal and at some conferences in the coming months. Everything about this hyperimmune, IgG-enriched bovine colostrum compound makes me excited
"These data suggest that oral administration of hyperimmune colostrum preparations can alleviate chronic inflammation, liver injury and insulin resistance associated with NASH."
"The data presented in our study show that Imm124-E is a safe oral treatment. No side effects were noted in any of the treated patients. Imm124-E led to a clear improvement in insulin resistance and to alleviation of related liver injury in NASH patients. These effects of Imm124-E were associated with an increased distribution of T regulatory lymphocytes and an improved lipid profile in treated patients.."
Add to My Watchlist
What is My Watchlist?
